Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia : A retrospective cohort study of the Relapsed AML 2001/01 Study
Autor: | Christine von Neuhoff, Dirk Reinhardt, Yves Bertrand, Kim Klein, Sarah Elitzur, Jonas Abrahamsson, Guy Leverger, Jacqueline Cloos, Ursula Creutzig, Valerie de Haas, Romy E. Van Weelderen, Pter Smisek, Martin Zimmermann, Henrik Hasle, Brenda Gibson, Alcira Fynn, Bassem I. Razzouk, Alexei Maschan, Shau Yin Ha, Michael Dworzak, Christine J. Harrison, H. Berna Beverloo, Carmelo Rizzari, Gertjan J.L. Kaspers, Susana C. Raimondi |
---|---|
Přispěvatelé: | Pediatric surgery, Hematology laboratory, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, Clinical Genetics, Klein, K, Beverloo, H, Zimmermann, M, Raimondi, S, von Neuhoff, C, de Haas, V, van Weelderen, R, Cloos, J, Abrahamsson, J, Bertrand, Y, Dworzak, M, Fynn, A, Gibson, B, Ha, S, Harrison, C, Hasle, H, Elitzur, S, Leverger, G, Maschan, A, Razzouk, B, Reinhardt, D, Rizzari, C, Smisek, P, Creutzig, U, Kaspers, G |
Jazyk: | angličtina |
Rok vydání: | 2022 |
Předmět: |
Oncology
PREDICTOR medicine.medical_specialty chromosomal instability IMPACT clonal evolution Medizin DIAGNOSIS FREQUENCY core-binding factor leukemia THERAPY Somatic evolution in cancer Cohort Studies pediatric acute myeloid leukemia/pediatric AML Recurrence Internal medicine Chromosome instability Humans Medicine Risk factor Child Retrospective Studies PEDIATRIC AML Chromosome Aberrations Chromosome 7 (human) cytogenetic business.industry pediatric acute myeloid leukemia Cytogenetics Myeloid leukemia Retrospective cohort study Karyotype Hematology Prognosis CYTOGENETICS MONOSOMAL KARYOTYPE karyotypic change(s) Leukemia Myeloid Acute Pediatrics Perinatology and Child Health business relapsed AML NEOPLASMS |
Zdroj: | Pediatric Blood and Cancer, 69(1):e29341. Wiley-Liss Inc. Klein, K, Beverloo, H B, Zimmermann, M, Raimondi, S C, von Neuhoff, C, de Haas, V, van Weelderen, R, Cloos, J, Abrahamsson, J, Bertrand, Y, Dworzak, M, Fynn, A, Gibson, B, Ha, S Y, Harrison, C J, Hasle, H, Elitzur, S, Leverger, G, Maschan, A, Razzouk, B, Reinhardt, D, Rizzari, C, Smisek, P, Creutzig, U & Kaspers, G J L 2022, ' Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia : A retrospective cohort study of the Relapsed AML 2001/01 Study ', Pediatric Blood and Cancer, vol. 69, no. 1, e29341 . https://doi.org/10.1002/pbc.29341 Klein, K, Beverloo, H B, Zimmermann, M, Raimondi, S C, von Neuhoff, C, de Haas, V, van Weelderen, R, Cloos, J, Abrahamsson, J, Bertrand, Y, Dworzak, M, Fynn, A, Gibson, B, Ha, S-Y, Harrison, C J, Hasle, H, Elitzur, S, Leverger, G, Maschan, A, Razzouk, B, Reinhardt, D, Rizzari, C, Smisek, P, Creutzig, U & Kaspers, G J L 2022, ' Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia : A retrospective cohort study of the Relapsed AML 2001/01 Study ', Pediatric Blood & Cancer, vol. 69, no. 1, e29341 . https://doi.org/10.1002/pbc.29341 |
ISSN: | 1545-5009 |
DOI: | 10.1002/pbc.29341 |
Popis: | BACKGROUND: In addition to treatment response, cytogenetic and molecular aberrations are the most important prognostic factors in children with de novo acute myeloid leukemia (AML). However, little is known about cytogenetics at the time of relapse.METHODS: This international study analyzed the prognostic value of cytogenetic profiles and karyotypic changes in pediatric relapsed AML in relation to the probability of event-free (pEFS) and overall survival (pOS). For this purpose, cytogenetic reports from all patients registered on the Relapsed AML 2001/01 Study were reviewed and classified.RESULTS: Cytogenetic information at relapse was available for 403 (71%) of 569 registered patients. Frequently detected aberrations at relapse were t(8;21)(q22;q22) (n = 60) and inv(16)(p13.1q22)/t(16;16)(p13.1;q22) (n = 24), both associated with relatively good outcome (4-year pOS 59% and 71%, respectively). Monosomy 7/7q-, t(9;11)(p22;q23), t(10;11)(p12;q23), and complex karyotypes were associated with poor outcomes (4-year pOS 17%, 19%, 22%, and 22%, respectively). Of 261 (65%) patients for whom cytogenetic data were reliable at both diagnosis and relapse, pEFS was inferior for patients with karyotypic instability (n = 128, 49%), but pOS was similar. Unstable karyotypes with both gain and loss of aberrations were associated with inferior outcome. Early treatment response, time to relapse, and cytogenetic profile at time of relapse were the most important prognostic factors, both outweighing karytoypic instability per se.CONCLUSION: The cytogenetic subgroup at relapse is an independent risk factor for (event-free) survival. Cytogenetic assessment at the time of relapse is of high importance and may contribute to improved risk-adapted treatment for children with relapsed AML. |
Databáze: | OpenAIRE |
Externí odkaz: |